How to Change Your Mind Review: The Psychedelic Hype Train Keeps Chugging
The Netflix documentary ‘How to Change Your Mind’ is great TV even though it fails to provide balanced coverage of psychedelics
The Netflix documentary ‘How to Change Your Mind’ is great TV even though it fails to provide balanced coverage of psychedelics
Psychedelic companies rely on novel patents to boost their value, but many players in the space are chasing the same IP
GoDaddy Founder Bob Parsons talks to Psychedelic Spotlight about treating PTSD with MDMA-assisted psychedelic therapy
Scientific discovery comes from creative insights, and a recently published review details how psychedelics can play a major role in scientific creativity.
Using a measurement tool called the SCR, researchers found that combining MDMA with fear extinction learning and recall therapy significantly reduced the fear felt by study participants, as compared to the placebo. This may have big implications for how we treat PTSD.
The history of MDMA is fascinating, and it is still being written.
A sexual misconduct scandal, a data scandal, and an elder abuse scandal haunt psychedelics leader MAPS, currently being scrutinized by Health Canada.
Psychiatrist, researcher, and CEO of Zylorion Health, Dr. Peter Silverstone, ranks psychedelic medicines based on their potential to revolutionize mental health treatment.
Another Michigan city decriminalizes psychedelic plants and fungi, while Maryland passes a bill to provide military veterans with cost-free access to healing medicines like ketamine, psilocybin, and MDMA.
Here’s why we think MAPS’ second Phase 3 MDMA trial is the most important psychedelic study of 2022, and 4 more that may have huge impacts.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.